Hinge Health Stock Surges 25%, With A 6-Day Winning Spree
Hinge Health (HNGE) – a software platform automating joint and muscle health care. – hit a 6-day winning streak, with cumulative gains over this period amounting to 25%. The company’s market cap has surged by about $878 Mil over the last 6 days and currently stands at $4.4 Bil.
Momentum often precedes conviction. A multi-day win streak can signal growing investor confidence or spark follow-on buying. Tracking such trends can help you ride the strength, or prepare for a well-timed entry if momentum fades.
But here is the interesting part. You are reading about this 25% move after it happened. The market has already priced in the news. To catch the next winner before the headlines, you need predictive signals, not notifications. High Quality Portfolio is based on an architecture that includes such signals.
Returns vs S&P 500
- How Low Can Shopify Stock Go?
- Nokia (NOK) Reset: Is the Infrastructure Giant Still Undervalued At $13?
- Is Universal Health Services Stock an Under-Analyzed Capital Compounder Opportunity?
- RadNet Earnings: AI Fuels Revenue Beat And Guidance Raise
- Intel Foundry’s $1 Trillion Upside
- Where Could The Next Breakout for Insmed Stock Come From
The following table summarizes the return for HNGE stock vs. the S&P 500 index over different periods, including the current streak:
| Return Period | HNGE | S&P 500 |
|---|---|---|
| 1D | 0.3% | -0.4% |
| 6D (Current Streak) | 25.0% | 2.8% |
| 1M (21D) | 43.6% | 8.2% |
| 3M (63D) | 73.0% | 7.9% |
| YTD 2026 | 18.4% | 7.2% |
| 2025 | 16.4% | |
| 2024 | 23.3% | |
| 2023 | 24.2% |
Gains and Losses Streaks: S&P 500 Constituents
There are currently 54 S&P constituents with 3 days or more of consecutive gains and 50 constituents with 3 days or more of consecutive losses.
| Consecutive Days | # of Gainers | # of Losers |
|---|---|---|
| 3D | 35 | 21 |
| 4D | 11 | 9 |
| 5D | 6 | 19 |
| 6D | 2 | 0 |
| 7D or more | 0 | 1 |
| Total >=3 D | 54 | 50 |
Key Financials for Hinge Health (HNGE)
Last 2 Fiscal Years:
| Metric | FY2024 | FY2025 |
|---|---|---|
| Revenues | $390.4 Mil | $587.9 Mil |
| Operating Income | $-31.9 Mil | $-546.4 Mil |
| Net Income | $-11.9 Mil | $-528.3 Mil |
Last 2 Fiscal Quarters:
| Metric | 2025 FQ3 | 2025 FQ4 |
|---|---|---|
| Revenues | $154.2 Mil | $170.7 Mil |
| Operating Income | $-6.1 Mil | $27.3 Mil |
| Net Income | $-1.8 Mil | $32.1 Mil |
While HNGE stock looks attractive given its winning streak, investing in a single stock without detailed, thorough analysis can be risky. The Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 — the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.